GPT and Thrombocytopenia: We also observed transient thrombocytopenia and lymphocytopenia, as well as rises in ALT 6 days after treatment, consistent with the reports of other sites undertaking P. vivax CHMI (9, 10, 55) and with no apparent impact on volunteer safety.